The Nigerian government initiates a transformative phase, harnessing the $933 million Global Fund grant to fortify health systems and combat HIV/AIDS, tuberculosis, and malaria from 2024 to 2026.
The Federal Government, in partnership with the ILO, launched a pioneering policy on HIV/AIDS, aimed at fostering inclusive workplaces nationwide.
The National AIDS and STI Control Programme (NASCP) has disclosed that Nigeria has successfully reduced the threat of HIV disease…
Salem Hospital faces a lawsuit alleging HIV and hepatitis exposure during intravenous (IV) treatments. Investigations ongoing; focus on patient assurance and accountability for past negligence.
Breakthrough study reveals the persistence of intact HIV sequences in the brain, raising questions about eradication and immune response.
Launches three-month sensitization program from October to December, focused on combating prevailing gender and human rights challenges faced by individuals living with or affected by HIV.
Nigeria’s Vice President, Kashim Shettima, reaffirmed the administration’s dedication to boost health financing and industry, drawing support from global health partners.
Pioneering research by Queen Mary University reveals Mpox vaccine’s potency in mitigating infection severity, affirming vaccination’s pivotal role.
Blood cancer drug, Venetoclax, has demonstrated potential in targeting dormant HIV cells, delaying reinfection, and moving closer to a potential cure.
Calls for partnership in boosting adolescent health while collaborating with Lagos State Agency for the Control of AIDS (LSACA) for a community outreach initiative.
Religious leaders have called for compassion in relating with people living with HIV in places of worship to ensure that the country achieves its target of ending new HIV infections by 2030.
In a groundbreaking revelation, scientists have finally unveiled the enigma behind the lower HIV viral loads observed in Africans, shedding light on a significant factor that has long remained elusive.
A recent study in Frontiers in Immunology reveals positive outcomes in the antibody response to COVID-19 infection and vaccination among individuals living with HIV (PLWH). The research highlights the potential impact of HIV treatment and vaccination on the immune response in this vulnerable population.
Acknowledges donors & advocates for their unwavering support in combating HIV/AIDS.